|ITEM METADATA RECORD
|Title: ||The B3A2 junction type of the BCR-ABL oncogene is a favorable prognostic factor for a complete response to interferon treatment in patients with chronic myeloid leukemia (CML)|
|Authors: ||Posthuma, EFM|
de Paus, R
Falkenburg, JHF #
|Issue Date: ||Nov-1998 |
|Publisher: ||W b saunders co|
|Host Document: ||Blood vol:92 issue:10 pages:93A-93A|
|Conference: ||ASH 40th Annual Meeting location:Miami Beach, Florida date:December 4-8, 1998|
|Publication status: ||published|
|KU Leuven publication type: ||IMa|
|Appears in Collections:||Department of Human Genetics - miscellaneous|
|Files in This Item:
There are no files associated with this item.
All items in Lirias are protected by copyright, with all rights reserved.
© Web of science